Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization

This publication has 34 references indexed in Scilit:

• PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION
  Retina, 2002
• Glucocorticoid-Regulated VEGF Expression in Ischemic Skeletal Muscle
  Molecular Therapy, 2002
• Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2
  American Journal of Ophthalmology, 2001
• LASER TREATMENTS WITH VERTEPORFIN THERAPY AND ITS POTENTIAL IMPACT ON RETINAL PRACTICES
  Retina, 2000
• The Microcirculation and Inflammation: Site of Action for Glucocorticoids
  Microcirculation, 2000
• INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
  Retina, 2000
• Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration
  Ophthalmology, 1999
• Evaluation of Angiogenic Inhibitors with anin vivoQuantitative Angiogenesis Method Using Agarose Microencapsulation and Mouse Hemoglobin Enzyme-linked Immunosorbent Assay
  Japanese Journal of Cancer Research, 1996
• Exudative macular degeneration and intravitreal triamcinolone A pilot study
  Australian and New Zealand Journal of Ophthalmology, 1995
• The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization
  Albrecht von Graefes Archiv für Ophthalmologie, 1993